Therapeutic Challenges for Cisplatin-Resistant Ovarian Germ Cell Tumors

The majority of patients with advanced ovarian germ cell cancer are treated by cisplatin-based chemotherapy. Despite adequate first-line treatment, nearly one third of patients relapse and almost half develop cisplatin-resistant disease, which is often fatal. The treatment of cisplatin-resistant dis...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Ugo De Giorgi, Chiara Casadei, Alice Bergamini, Laura Attademo, Gennaro Cormio, Domenica Lorusso, Sandro Pignata, Giorgia Mangili
Format: Artigo
Langue:Inglês
Publié: MDPI AG 2019-10-01
Collection:Cancers
Sujets:
female patients
germ cell tumors
ovarian germ cell tumors
salvage therapy
refractory
high-dose chemotherapy
Accès en ligne:https://www.mdpi.com/2072-6694/11/10/1584
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires